Signature Diagnostics Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 15

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $31.9M

Signature Diagnostics General Information

Description

Provider of development and commercialization of molecular oncology diagnostic products for early detection and prognosis of cancer. The company has completed development of its first two diagnostic products for colorectal cancer screening ("Detector C/C+") and prognosis ("Predictor C"), which will be launched in 2012 in its own ISO 15189 certified service laboratory. Using its technologies in tissue and blood sample collection, molecular pathology, Xenopatient™ platform, genome-wide profiling, data mining, and biostatistics, the company collaborates with clinical, pharmaceutical, and diagnostic partners. The company sponsors and conducts large prospective, multicenter clinical trials with more than 33 primary care hospitals and several dozen colonoscopy centers in Germany to discover and validate biomarkers in oncology.

Contact Information

Formerly Known As
Signature Diagnostics Aktiengesellschaft
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Hermannswerder 20 A
  • 14473 Potsdam
  • Germany
+49 0331
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Acquirer
Vertical(s)
Corporate Office
  • Hermannswerder 20 A
  • 14473 Potsdam
  • Germany
+49 0331

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Signature Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 12-Feb-2015 $31.9M Completed Generating Revenue
4. Later Stage VC (Series C) 12-Aug-2008 Completed Generating Revenue
3. Early Stage VC (Series B) 30-Jan-2008 Completed Generating Revenue
2. Grant 20-Jun-2005 $1.35M Completed Generating Revenue
1. Early Stage VC 22-Apr-2005 Completed Generating Revenue
To view Signature Diagnostics’s complete valuation and funding history, request access »

Signature Diagnostics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of development and commercialization of molecular oncology diagnostic products for early detection and prognosi
Biotechnology
Potsdam, Germany
15 As of 2024

Princeton, NJ
 

Ladenburg, Germany
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Signature Diagnostics Competitors (3)

One of Signature Diagnostics’s 3 competitors is Bristol-Myers Squibb, a Corporation company based in Princeton, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Bristol-Myers Squibb Corporation Princeton, NJ
Heidelberg Pharma Formerly VC-backed Ladenburg, Germany
Ability Pharma Private Equity-Backed Cerdanyola, Spain
You’re viewing 3 of 3 competitors. Get the full list »

Signature Diagnostics Patents

Signature Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2759605-A1 A method for predicting a manifestation of an outcome measure of a cancer patient Active 25-Jan-2013
EP-2759605-B1 A method for predicting a manifestation of an outcome measure of a cancer patient Inactive 25-Jan-2013
US-20140342925-A1 Method for predicting a manifestation of an outcome measure of a cancer patient Inactive 25-Jan-2013
US-20160153032-A9 Method for predicting a manifestation of an outcome measure of a cancer patient Inactive 25-Jan-2013
EP-2524967-A1 Methods and kits for diagnosing colorectal cancer Inactive 19-May-2011 C12Q1/6886
To view Signature Diagnostics’s complete patent history, request access »

Signature Diagnostics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Signature Diagnostics Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Brandenburg Kapital Venture Capital Minority
COI Partners Growth/Expansion Minority
EVP Capital Management Growth/Expansion Minority
IBG Beteiligungsgesellschaft Sachsen-Anhalt Venture Capital Minority
KfW IPEX-Bank Investment Bank Minority
You’re viewing 5 of 7 investors. Get the full list »

Signature Diagnostics FAQs

  • When was Signature Diagnostics founded?

    Signature Diagnostics was founded in 2004.

  • Where is Signature Diagnostics headquartered?

    Signature Diagnostics is headquartered in Potsdam, Germany.

  • What is the size of Signature Diagnostics?

    Signature Diagnostics has 15 total employees.

  • What industry is Signature Diagnostics in?

    Signature Diagnostics’s primary industry is Biotechnology.

  • Is Signature Diagnostics a private or public company?

    Signature Diagnostics is a Private company.

  • What is the current valuation of Signature Diagnostics?

    The current valuation of Signature Diagnostics is .

  • What is Signature Diagnostics’s current revenue?

    The current revenue for Signature Diagnostics is .

  • How much funding has Signature Diagnostics raised over time?

    Signature Diagnostics has raised $7.92M.

  • Who are Signature Diagnostics’s investors?

    Brandenburg Kapital, COI Partners, EVP Capital Management, IBG Beteiligungsgesellschaft Sachsen-Anhalt, and KfW IPEX-Bank are 5 of 7 investors who have invested in Signature Diagnostics.

  • Who are Signature Diagnostics’s competitors?

    Bristol-Myers Squibb, Heidelberg Pharma, and Ability Pharma are competitors of Signature Diagnostics.

  • When was Signature Diagnostics acquired?

    Signature Diagnostics was acquired on 12-Feb-2015.

  • Who acquired Signature Diagnostics?

    Signature Diagnostics was acquired by Roche.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process